<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archivearticle1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4029829</article-id><article-id pub-id-type="pmid">24849241</article-id><article-id pub-id-type="publisher-id">PONE-D-14-09161</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0097765</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Clinical Immunology</subject><subj-group><subject>Immunopathology</subject></subj-group></subj-group></subj-group><subj-group><subject>Microbiology</subject><subj-group><subject>Virology</subject><subj-group><subject>Viral Genes</subject><subject>Viral Persistence and Latency</subject><subject>Virus Effects on Host Gene Expression</subject></subj-group></subj-group></subj-group><subj-group><subject>Veterinary Science</subject><subj-group><subject>Veterinary Diseases</subject><subj-group><subject>Veterinary Virology</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Expression of Ovine Herpesvirus -2 Encoded MicroRNAs in an Immortalised Bovine – Cell Line </plain></SENT>
</text></SecTag></article-title><alt-title alt-title-type="running-head">Ovine Herpesvirus -2 Encoded MicroRNAs</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nightingale</surname><given-names>Katie</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Levy</surname><given-names>Claire S.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="author-notes" rid="fn1">
<sup>¤</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hopkins</surname><given-names>John</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Grey</surname><given-names>Finn</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Esper</surname><given-names>Suzanne</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Dalziel</surname><given-names>Robert G.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>The Roslin Institute &amp; R(D)SVS, University of Edinburgh, Edinburgh, Midlothian, United Kingdom</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Stewart</surname><given-names>James P.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>University of Liverpool, United Kingdom</addr-line>
</aff><author-notes><corresp id="cor1">* E-mail: <email>bob.dalziel@roslin.ed.ac.uk</email></corresp><fn fn-type="COI-statement"><p><text><SENT sid="1" pm="."><plain>Competing Interests: The authors have declared that no competing interests exist. </plain></SENT>
</text></p></fn><fn fn-type="con"><p><text><SENT sid="2" pm="."><plain>Conceived and designed the experiments: KN RGD JH FG. </plain></SENT>
<SENT sid="3" pm="."><plain>Performed the experiments: KN CSL SE. </plain></SENT>
<SENT sid="4" pm="."><plain>Analyzed the data: KN JH FG RGD. </plain></SENT>
<SENT sid="5" pm="."><plain>Wrote the paper: RGD. </plain></SENT>
</text></p></fn><fn id="fn1" fn-type="current-aff"><label>¤</label><p><text><SENT sid="6" pm="."><plain>Current address: The Scripps Research Institute, La Jolla, California, United States of America </plain></SENT>
</text></p></fn></author-notes><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>21</day><month>5</month><year>2014</year></pub-date><volume>9</volume><issue>5</issue><elocation-id>e97765</elocation-id><history><date date-type="received"><day>28</day><month>2</month><year>2014</year></date><date date-type="accepted"><day>22</day><month>4</month><year>2014</year></date></history><permissions><copyright-statement>© 2014 Nightingale et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Nightingale et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="7" pm="."><plain>Ovine herpesvirus-2 (OvHV-2) infects most sheep, where it establishes an asymptomatic, latent infection. </plain></SENT>
<SENT sid="8" pm="."><plain>Infection of susceptible hosts e.g. cattle and deer results in malignant catarrhal fever, a fatal lymphoproliferative disease characterised by uncontrolled lymphocyte proliferation and non MHC restricted cytotoxicity. </plain></SENT>
<SENT sid="9" pm="."><plain>The same cell populations are infected in both cattle and sheep but only in cattle does virus infection cause dysregulation of cell function leading to disease. </plain></SENT>
<SENT sid="10" pm="."><plain>The mechanism by which OvHV-2 induces this uncontrolled proliferation is unknown. </plain></SENT>
<SENT sid="11" pm="."><plain>A number of herpesviruses have been shown to encode microRNAs (miRNAs) that have roles in control of both viral and cellular gene expression. </plain></SENT>
<SENT sid="12" pm="."><plain>We hypothesised that OvHV-2 encodes miRNAs and that these play a role in pathogenesis. </plain></SENT>
<SENT sid="13" pm="."><plain>Analysis of massively parallel sequencing data from an OvHV-2 persistently-infected bovine lymphoid cell line (BJ1035) identified forty-five possible virus-encoded miRNAs. </plain></SENT>
<SENT sid="14" pm="."><plain>We previously confirmed the expression of eight OvHV-2 miRNAs by northern hybridization. </plain></SENT>
<SENT sid="15" pm="."><plain>In this study we used RT-PCR to confirm the expression of an additional twenty-seven OvHV-2-encoded miRNAs. </plain></SENT>
<SENT sid="16" pm="."><plain>All thirty-five OvHV-2 miRNAs are expressed from the same virus genome strand and the majority (30) are encoded in an approximately 9 kb region that contains no predicted virus open reading frames. </plain></SENT>
<SENT sid="17" pm="."><plain>Future identification of the cellular and virus targets of these miRNAs will inform our understanding of MCF pathogenesis. </plain></SENT>
</text></SecTag></p></abstract><funding-group><funding-statement>KN is funded by a University of Edinburgh Principal's Career Development Scholarship and the Roslin Institute, SE was funded by Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant to The Roslin Institute, FG is a Wellcome Trust Career Development Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="6"/></counts></article-meta></front><body><SecTag type="INTRO"><sec id="s1"><title><text><SENT sid="18" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="19" pm="."><plain>Malignant catarrhal fever (MCF) is a fatal disease of cattle, deer and pigs caused by one of two related gammaherpesviruses (γ-HV), ovine herpesvirus -2 (OvHV-2) or alcelaphine herpesvirus 1 (AlHV-1). </plain></SENT>
<SENT sid="20" pm="."><plain>MCF is characterized by sudden onset of fever followed by lymphadenopathy, leukocytosis, severe congestion, necrosis and erosion of the oral, conjuctival and nasal mucosæ [1]. </plain></SENT>
<SENT sid="21" pm="."><plain>The disease occurs as the result of infection of susceptible hosts by contact with an asymptomatic carrier species that acts as a virus reservoir. </plain></SENT>
<SENT sid="22" pm="."><plain>OvHV-2 is the major cause of sheep associated MCF worldwide [1]. </plain></SENT>
<SENT sid="23" pm="."><plain>It infects most sheep, where it establishes a latent but asymptomatic infection. </plain></SENT>
<SENT sid="24" pm="."><plain>AlHV-1 is the major cause of MCF in sub-Saharan Africa where the wildebeest is the asymptomatic carrier species. </plain></SENT>
</text></p><p><text><SENT sid="25" pm="."><plain>The same cell populations are infected in both cattle and sheep [2], [3] but only in cattle does virus infection cause dysregulation of cell function leading to uncontrolled proliferation, cytotoxicity and disease. </plain></SENT>
<SENT sid="26" pm="."><plain>In both species the infected cells arise from common lymphoid progenitors [4] but interleukin 2-dependent cell lines can be cultured only from affected animals. </plain></SENT>
<SENT sid="27" pm="."><plain>There is currently no tissue culture system for OvHV-2 and such cell lines are the only resource for working with the virus. </plain></SENT>
<SENT sid="28" pm="."><plain>In affected species the infected cells have been described as large granular lymphocytes (LGLs) [5]. </plain></SENT>
<SENT sid="29" pm="."><plain>The immortalized cell lines have a variety of phenotypes; all express CD2 but vary in their expression of CD4 and CD8 [2], [3]. </plain></SENT>
<SENT sid="30" pm="."><plain>The mechanism by which OvHV-2 induces MCF is unknown; virus-induced cytopathology is thought not to be involved in lesion development and it has been proposed that tissue damage arises from non-antigen specific, MHC unrestricted cytotoxicity of the LGLs. </plain></SENT>
<SENT sid="31" pm="."><plain>The key question in understanding OvHV-2 pathogenesis is; why infection of the same cell type in two closely related species leads to such different disease outcomes, i.e. lymphoid cell dysregulation and MCF in cattle versus asymptomatic infection in sheep. </plain></SENT>
</text></p><p><text><SENT sid="32" pm="."><plain>MicroRNAs (miRNAs) constitute a large family of small, non-coding RNAs functioning in post-transcriptional regulation of mRNA in eukaryotes [6]–[8] as well as in a number of viruses, particularly in the members of the family Herpesviridae [9]–[11]. </plain></SENT>
<SENT sid="33" pm="."><plain>miRNA regulation of expression is by binding of the miRNA seed sequence (∼nucleotides 2–8) to complementary sequences in target mRNAs and directing these for degradation or translational silencing; the majority of miRNAs target sequences within the 3′ UTR [6]. </plain></SENT>
<SENT sid="34" pm="."><plain>Herpesvirus-encoded miRNAs have been shown to be effective regulators of both cellular and virus gene expression and to influence cell processes including the cell cycle [12]–[17]. </plain></SENT>
<SENT sid="35" pm="."><plain>The pathology of the herpesviruses Epstein Barr virus (EBV) and Marek's disease virus (MDV) also involves aberrant lymphocyte proliferation, and virus-encoded miRNAs play a key role in the induction of this proliferation. </plain></SENT>
<SENT sid="36" pm="."><plain>Furthermore, deletion of a single (MDV) or a small cluster (EBV) of virus-encoded miRNAs attenuates these viruses [18]–[20]. </plain></SENT>
<SENT sid="37" pm="."><plain>Consequently we hypothesized that OvHV-2 encodes miRNAs that target host mRNAs and that these constrain virus pathology in sheep and/or induce MCF pathology in cattle. </plain></SENT>
<SENT sid="38" pm="."><plain>Identification and characterization of OvHV-2-encoded miRNAs is therefore essential to allow this hypothesis to be addressed. </plain></SENT>
</text></p><p><text><SENT sid="39" pm="."><plain>In a previous study we reported the results of massively parallel sequencing of small RNAs present in the BJ1035 OvHV-2 immortalized bovine LGL cell line and predicted that the virus encodes up to forty-five miRNAs [21]. </plain></SENT>
<SENT sid="40" pm="."><plain>Eight of these were confirmed by northern hybridization [22]. </plain></SENT>
<SENT sid="41" pm="."><plain>Here we extend these studies using two PCR protocols to investigate the expression of the other predicted OvHV-2 miRNAs. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="methods" id="s2"><title><text><SENT sid="42" pm="."><plain>Methods </plain></SENT>
</text></title><sec id="s2a"><title><text><SENT sid="43" pm="."><plain>Cell culture </plain></SENT>
</text></title><p><text><SENT sid="44" pm="."><plain>BJ1035 cells, an immortalized bovine T cell line from an animal naturally infected with OvHV-2 [3], was grown in suspension culture in Iscove's Modified Dulbecco's Medium (Invitrogen, Paisley, UK) supplemented with 10% (v/v) foetal calf serum (Sera Laboratories International, Haywards Heath, UK), 1% (v/v) penicillin-streptomycin (Invitrogen), 20 U/ml interleukin 2 (Novartis Pharmaceuticals UK, Camberley, UK) and incubated at 37°C, 5% CO2. </plain></SENT>
<SENT sid="45" pm="."><plain>Bovine lymphoid cells were isolated from fresh blood and lymphoblasts generated as described previously [23]. </plain></SENT>
<SENT sid="46" pm="."><plain>All relevant procedures were approved by the University of Edinburgh Ethical Review Committee and carried out under an Animal (Scientific Procedures) Act 1996 project licence. </plain></SENT>
</text></p></sec><sec id="s2b"><title><text><SENT sid="47" pm="."><plain>Reverse Transcription PCR (RT-PCR) </plain></SENT>
</text></title><p><text><SENT sid="48" pm="."><plain>Bovine lymphoblasts and BJ1035 cells were pelleted by centrifugation and total RNA extracted using Trizol (Invitrogen). </plain></SENT>
<SENT sid="49" pm="."><plain>cDNA was generated using the miScript II RT Kit (Qiagen, Crawley, UK) that uses oligo-dT to prime reverse transcription. </plain></SENT>
<SENT sid="50" pm="."><plain>For each predicted miRNA, a specific forward primer spanning the first 15–16 nucleotides of the miRNA was designed (Table S1) allowing subsequent sequence confirmation of the identity of the amplified miRNA RT-PCR was performed using miScript SYBR green PCR kit (Qiagen), with the supplied universal reverse primer and the miRNA specific forward primers using the annealing temperatures shown in Table S1. </plain></SENT>
<SENT sid="51" pm="."><plain>PCR products were fractionated by electrophoresis using 3% agarose, purified using the Illustra GFX PCR DNA and Gel Band Purification Kits (GE Healthcare, Amersham, UK) and cloned using the TOPO TA Cloning Kit (Invitrogen). </plain></SENT>
<SENT sid="52" pm="."><plain>Plasmid DNA was isolated using the Qiaprep Spin Miniprep Kit (Qiagen), analysed by restriction enzyme digestion and sequenced (GATC Biotech, London UK). </plain></SENT>
</text></p></sec><sec id="s2c"><title><text><SENT sid="53" pm="."><plain>miRNA specific reverse transcription </plain></SENT>
</text></title><p><text><SENT sid="54" pm="."><plain>Individual miRNA specific primers (Table S2) were used to prime for reverse transcriptase. </plain></SENT>
<SENT sid="55" pm="."><plain>Each primer also has a 5′ conserved region recognised by a universal reverse primer (5′- GTGCAGGGTCCGAGGT-3′) [24]. </plain></SENT>
<SENT sid="56" pm="."><plain>An initial reaction to form the hairpin structure of the reverse transcription primer (200 µM) was carried out using the following conditions: 95°C for 30 min, 72°C for 2 min, 37°C for 2 min then 25°C for 2 min. </plain></SENT>
<SENT sid="57" pm="."><plain>The concentration of the reverse transcription primer after annealing was 50 µM. </plain></SENT>
<SENT sid="58" pm="."><plain>For the reverse transcription reaction 5 µM reverse transcription primer was used to prime 100 ng of RNA. </plain></SENT>
<SENT sid="59" pm="."><plain>Conditions for the reverse transcription reaction were as follows: 16°C for 30 min, 42°C for 30 min then 85°C for 5 min. </plain></SENT>
<SENT sid="60" pm="."><plain>PCR was thenperformed using miRNA specific forward primers (Table S2) and the following conditions: 5 min at 95°C, 40 cycles of: 30 s at 95°C, 30 s at 60°C, 60 s at 72°C; then finally 7 min at 72°C. </plain></SENT>
<SENT sid="61" pm="."><plain>PCR products were fractionated by electrophoresis using 3% agarose. </plain></SENT>
<SENT sid="62" pm="."><plain>Reactions were performed in triplicate. </plain></SENT>
<SENT sid="63" pm="."><plain>The presence of a product in the BJ1035 cells but not in the uninfected bovine lymphoblast cells was taken as proof of OvHV-2 miRNA expression. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec id="s3"><title><text><SENT sid="64" pm="."><plain>Results </plain></SENT>
</text></title><p><text><SENT sid="65" pm="."><plain>Using northern hybridization we have previously demonstrated the expression of the eight of the 45 predicted miRNAs that were represented by the highest number of reads in our parallel sequencing data [22]. </plain></SENT>
<SENT sid="66" pm="."><plain>RT-PCR using miRNA specific forward primers and a universal reverse primer for the remaining 37 predicted miRNAs initially identified 22 virus-encoded miRNAs (Table S1, Table 1). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0097765-t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0097765.t001</object-id><label>Table 1</label><caption><title><text><SENT sid="67" pm="."><plain>OvHV-2-encoded microRNAs. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0097765-t001-1" xlink:href="pone.0097765.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="68" pm="."><plain>ovhv2-miR- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="69" pm="."><plain>Previous name </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="70" pm="."><plain>Abundance RNA-seq </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="71" pm="."><plain>Walz et al. </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="72" pm="."><plain>5′nt </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="73" pm="."><plain>3′nt </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="74" pm="."><plain>Sequence </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="75" pm="."><plain>Validation Method </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="76" pm="."><plain>Ov2-2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="77" pm="."><plain>miR-1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="78" pm="."><plain>10588 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="79" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="80" pm="."><plain>927 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="81" pm="."><plain>906 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="82" pm="."><plain>AAGGCUUGAUAAGUAGCACUGA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="83" pm="."><plain>Levy et al. </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="84" pm="."><plain>Ov2-1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="85" pm="."><plain>253 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="86" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="87" pm="."><plain>1182 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="88" pm="."><plain>1161 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="89" pm="."><plain>AUGCUUGUUUAGGCCCCAUGAA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="90" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="91" pm="."><plain>17-30 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="92" pm="."><plain>434 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="93" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="94" pm="."><plain>27722 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="95" pm="."><plain>27702 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="96" pm="."><plain>UUUGGGUGUCUCCUGUCAUCU </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="97" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="98" pm="."><plain>17-29 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="99" pm="."><plain>miR-2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="100" pm="."><plain>39169 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="101" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="102" pm="."><plain>27903 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="103" pm="."><plain>27881 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="104" pm="."><plain>AUCUUGGACGCAUCUGUCAGUAG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="105" pm="."><plain>Levy et al. </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="106" pm="."><plain>17-28 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="107" pm="."><plain>6200 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="108" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="109" pm="."><plain>28066 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="110" pm="."><plain>28045 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="111" pm="."><plain>UCUAGGUUGCAUUUUGCUGUAG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="112" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="113" pm="."><plain>17-27 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="114" pm="."><plain>6015 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="115" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="116" pm="."><plain>28209 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="117" pm="."><plain>28188 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="118" pm="."><plain>CCCACAUUUAAGGUGCUCGUGU </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="119" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="120" pm="."><plain>17-26 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="121" pm="."><plain>322 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="122" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="123" pm="."><plain>28381 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="124" pm="."><plain>28361 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="125" pm="."><plain>AUAUUCGUUUAGACGCAAGUA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="126" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="127" pm="."><plain>17-25 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="128" pm="."><plain>4717 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="129" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="130" pm="."><plain>28515 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="131" pm="."><plain>28495 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="132" pm="."><plain>CAAUGCUGCUUUGGUGCCUCA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="133" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="134" pm="."><plain>17-24 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="135" pm="."><plain>1014 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="136" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="137" pm="."><plain>28683 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="138" pm="."><plain>28661 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="139" pm="."><plain>GGGUUCCUCGAGUGGAUAUUGUU </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="140" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="141" pm="."><plain>17-23 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="142" pm="."><plain>21686 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="143" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="144" pm="."><plain>28781 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="145" pm="."><plain>28761 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="146" pm="."><plain>AUACACACUGAAAGAGCUAGA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="147" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="148" pm="."><plain>17-22 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="149" pm="."><plain>740 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="150" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="151" pm="."><plain>28888 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="152" pm="."><plain>28866 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="153" pm="."><plain>AUAAGGCCAACACUAGGUGCUGU </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="154" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="155" pm="."><plain>17-21 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="156" pm="."><plain>31227 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="157" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="158" pm="."><plain>29052 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="159" pm="."><plain>29028 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="160" pm="."><plain>AAGCACCUUGGGUGAUGUCUCUGUU </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="161" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="162" pm="."><plain>17-20 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="163" pm="."><plain>miR-3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="164" pm="."><plain>14694 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="165" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="166" pm="."><plain>29248 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="167" pm="."><plain>29226 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="168" pm="."><plain>UCUGUAUCAUAGGGGUUGUGUUG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="169" pm="."><plain>Levy et al. </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="170" pm="."><plain>17-19 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="171" pm="."><plain>6487 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="172" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="173" pm="."><plain>29345 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="174" pm="."><plain>29323 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="175" pm="."><plain>AAGCAUAGCUGGGAGUGUCUAGA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="176" pm="."><plain>Specific cDNA </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="177" pm="."><plain>17-18 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="178" pm="."><plain>9219 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="179" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="180" pm="."><plain>29455 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="181" pm="."><plain>29434 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="182" pm="."><plain>UAGUAGUCCGUUAACGCAAAGU </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="183" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="184" pm="."><plain>17-17 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="185" pm="."><plain>miR-4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="186" pm="."><plain>17508 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="187" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="188" pm="."><plain>29637 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="189" pm="."><plain>29616 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="190" pm="."><plain>AAGGAUCCUUAAGUGACGAACG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="191" pm="."><plain>Levy et al- </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="192" pm="."><plain>17-16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="193" pm="."><plain>8095 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="194" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="195" pm="."><plain>29745 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="196" pm="."><plain>29725 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="197" pm="."><plain>UAAACUGGUGGUAGGCGGUCU </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="198" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="199" pm="."><plain>17-15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="200" pm="."><plain>2967 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="201" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="202" pm="."><plain>29945 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="203" pm="."><plain>29923 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="204" pm="."><plain>UAGCAGUUAUGCAGGUAUCUGGU </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="205" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="206" pm="."><plain>17-14 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="207" pm="."><plain>3794 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="208" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="209" pm="."><plain>30091 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="210" pm="."><plain>30067 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="211" pm="."><plain>UGGCAUUUCCAGGAGCCUGUUGUUC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="212" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="213" pm="."><plain>17-13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="214" pm="."><plain>24497 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="215" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="216" pm="."><plain>30338 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="217" pm="."><plain>30316 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="218" pm="."><plain>UUGGGUCCAACAUGAGACGCGGU </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="219" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="220" pm="."><plain>17-12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="221" pm="."><plain>14966 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="222" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="223" pm="."><plain>30510 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="224" pm="."><plain>30489 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="225" pm="."><plain>UAUGUCAGAAGUGAAGCUGAGA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="226" pm="."><plain>Specific cDNA </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="227" pm="."><plain>17-11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="228" pm="."><plain>1357 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="229" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="230" pm="."><plain>30632 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="231" pm="."><plain>30611 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="232" pm="."><plain>UGGUUUGCAUCUGCACCCAGUU </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="233" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="234" pm="."><plain>17-10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="235" pm="."><plain>miR-5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="236" pm="."><plain>11187 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="237" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="238" pm="."><plain>30818 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="239" pm="."><plain>30796 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="240" pm="."><plain>UGAAGUUACAGCUGCACCUGGAU </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="241" pm="."><plain>Levy et al. </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="242" pm="."><plain>17-9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="243" pm="."><plain>5457 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="244" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="245" pm="."><plain>30980 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="246" pm="."><plain>30956 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="247" pm="."><plain>UAGAGUUACUAAGGAUUCCCUGGUA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="248" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="249" pm="."><plain>17-8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="250" pm="."><plain>942 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="251" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="252" pm="."><plain>31085 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="253" pm="."><plain>31066 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="254" pm="."><plain>AAUCGCCGGUGGCCUUCUAG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="255" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="256" pm="."><plain>17-7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="257" pm="."><plain>351 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="258" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="259" pm="."><plain>31359 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="260" pm="."><plain>31340 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="261" pm="."><plain>UAUAGACGGGUAUGCUGCCG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="262" pm="."><plain>Specific cDNA </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="263" pm="."><plain>17-6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="264" pm="."><plain>miR-6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="265" pm="."><plain>10378 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="266" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="267" pm="."><plain>31462 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="268" pm="."><plain>31440 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="269" pm="."><plain>UAUUUUUAGCGGAGACCUCUAGG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="270" pm="."><plain>Levy et al. </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="271" pm="."><plain>17-5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="272" pm="."><plain>1535 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="273" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="274" pm="."><plain>31603 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="275" pm="."><plain>31582 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="276" pm="."><plain>CCUUUUUGGUGAGUUGCCCUGU </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="277" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="278" pm="."><plain>17-4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="279" pm="."><plain>517 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="280" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="281" pm="."><plain>32075 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="282" pm="."><plain>32054 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="283" pm="."><plain>GAUUUGAUAAAGCCUGCCUGCG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="284" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="285" pm="."><plain>17-3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="286" pm="."><plain>miR-7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="287" pm="."><plain>16574 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="288" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="289" pm="."><plain>36313 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="290" pm="."><plain>36289 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="291" pm="."><plain>GAAGGCGCAUCAUAGACACCACUUC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="292" pm="."><plain>Levy et al. </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="293" pm="."><plain>17-2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="294" pm="."><plain>7834 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="295" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="296" pm="."><plain>36462 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="297" pm="."><plain>36441 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="298" pm="."><plain>ACCCCGGGGGUAUGUGCAGGAC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="299" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="300" pm="."><plain>17-1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="301" pm="."><plain>miR-8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="302" pm="."><plain>46048 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="303" pm="."><plain>√ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="304" pm="."><plain>36575 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="305" pm="."><plain>36554 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="306" pm="."><plain>UGGCUCAGCGUGACUGCUCUUC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="307" pm="."><plain>Levy et al. </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="308" pm="."><plain>24-1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="309" pm="."><plain>1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="310" pm="."><plain>x </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="311" pm="."><plain>48585 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="312" pm="."><plain>48560 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="313" pm="."><plain>GAGCAGUACUACACAGCAGACAACAU </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="314" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="315" pm="."><plain>61-1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="316" pm="."><plain>1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="317" pm="."><plain>x </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="318" pm="."><plain>96435 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="319" pm="."><plain>96411 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="320" pm="."><plain>UUGGGGACGUGCUGGCUGACGACGU </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="321" pm="."><plain>Specific cDNA </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="322" pm="."><plain>73-1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="323" pm="."><plain>6064 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="324" pm="."><plain>x </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="325" pm="."><plain>117122 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="326" pm="."><plain>117100 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="327" pm="."><plain>UAAUCUCUGCUCCAAUUGUAAAU </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="328" pm="."><plain>Specific cDNA </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label/><p><text><SENT sid="329" pm="."><plain>The 35 validated miRNAs are listed. Previous name: designation in Levy et al. 2012. Abundance (RNA-seq): Total number of sequence tags representing the miRNA in the RNA-seq data [22]. Walz  et al .: miRNAs predicted by Walz et al. √ = yes; X = no. 5′nt/3′nt: the first and last nucleotides of the mature miRNA on the OvHV-2 genome (AY839756) [28]. Sequence: sequence of the mature miRNA. Validation method: Levy et al.: validated previously [22]; Sequencing: validated using the RT-PCR and subsequent sequencing; Specific cDNA: validated using the approach of Varkonyi-Gasic et al.[24]. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="330" pm="."><plain>To investigate if the remaining 15 miRNAs are expressed, an alternative miRNA specific reverse transcription PCR strategy was adopted. </plain></SENT>
<SENT sid="331" pm="."><plain>The expression of a predicted miRNA (ovhv2-miR-73-1) that was shown to have seed sequence homology but no 3′ sequence homology with mammalian miR-216a (Figure 1) was also analysed by this method. </plain></SENT>
<SENT sid="332" pm="."><plain>The presence of a product in the BJ1035 cells but not in the uninfected bovine lymphoblast cells was taken as proof of OvHV-2 miRNA expression. </plain></SENT>
<SENT sid="333" pm="."><plain>As the forward primer ends at the nucleotide adjacent to that from which cDNA is primed, sequencing of the product would generate only primer sequence. </plain></SENT>
<SENT sid="334" pm="."><plain>To confirm that amplification was from miRNA and not genomic DNA a no RT control was performed and no amplification was observed with any primer set. </plain></SENT>
<SENT sid="335" pm="."><plain>Expression of a further 5 miRNAs, including ovhv2-miR-73-1, was confirmed, (Figure 2). Figure 3 shows the location and direction of transcription of the thirty-five validated OvHV-2-encoded miRNAs. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0097765-g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0097765.g001</object-id><label>Figure 1</label><caption><title><text><SENT sid="336" pm="."><plain>Comparison of the sequences of ovhv2-miR-73-1 and miR-216a. </plain></SENT>
</text></title><p><text><SENT sid="337" pm="."><plain>Seed sequences (nt 1-7) are shown in red. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0097765.g001"/></fig></SecTag><SecTag type="FIG"><fig id="pone-0097765-g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0097765.g002</object-id><label>Figure 2</label><caption><title><text><SENT sid="338" pm="."><plain>Analysis of OvHV-2-encoded miRNA expression using miRNA specific RT-PCR. </plain></SENT>
</text></title><p><text><SENT sid="339" pm="."><plain>A) Expression of five predicted OvHV-2-encoded miRNAs in BJ1035 cells but not uninfected bovine lymphoblasts was confirmed by miRNA specific RT-PCR. </plain></SENT>
<SENT sid="340" pm="."><plain>Each assay was carried out in triplicate. </plain></SENT>
<SENT sid="341" pm="."><plain>M: 50 bp and 100 bp markers B) miRNA specific RT-PCR was carried out along with an no RT (-RT) control. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0097765.g002"/></fig></SecTag><SecTag type="FIG"><fig id="pone-0097765-g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0097765.g003</object-id><label>Figure 3</label><caption><title><text><SENT sid="342" pm="."><plain>Location of miRNAs in the OvHV-2 genome. </plain></SENT>
</text></title><p><text><SENT sid="343" pm="."><plain>A) The relative positions of the predicted miRNAs in the OvHV-2 genome are shown. </plain></SENT>
<SENT sid="344" pm="."><plain>Numbering is from Hart et al.[28]. </plain></SENT>
<SENT sid="345" pm="."><plain>The genome is represented by a thin line and open reading frames (ORFs) are indicated by blue boxes. </plain></SENT>
<SENT sid="346" pm="."><plain>Boxes above the line represent ORFs transcribed left to right; those below the line represent ORFs which are transcribed right to left. </plain></SENT>
<SENT sid="347" pm="."><plain>Only those ORFs adjacent to predicted miRNAs are named. </plain></SENT>
<SENT sid="348" pm="."><plain>Arrows indicate the position of the predicted miRNAs; arrows above the line represent miRNAs transcribed left to right, those below the line represent miRNAs which are transcribed right to left. </plain></SENT>
<SENT sid="349" pm="."><plain>Dark blue vertical arrows indicate validated miRNAs. </plain></SENT>
<SENT sid="350" pm="."><plain>Red arrows indicate non-validated miRNAs named according to the groups listed in Table 1. </plain></SENT>
<SENT sid="351" pm="."><plain>Those OvHV-2 ORFs closest to validated miRNAs and after which those miRNAs are named are shown in darkblue. </plain></SENT>
<SENT sid="352" pm="."><plain>B) The locations of ovhv2-miR-17-1 to -30 are shown in more detail. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0097765.g003"/></fig></SecTag></sec></SecTag><SecTag type="DISCUSS"><sec id="s4"><title><text><SENT sid="353" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="354" pm="."><plain>The number of miRNAs expressed by individual herpesviruses ranges from 8 to 50 [25] and here we demonstrate that OvHV-2 encodes 35 miRNAs. </plain></SENT>
<SENT sid="355" pm="."><plain>Using a predictive algorithm Walz et al. [26] predicted 61 hairpin sites in OvHV-2 that might encode miRNAs; 32 of which we have now confirmed to be expressed (Figure 3, Table 1), three of our validated miRNAs were not predicted by Walz et al.. </plain></SENT>
<SENT sid="356" pm="."><plain>All of the validated miRNAs expressed by OvHV-2 are transcribed in the same orientation, right to left. </plain></SENT>
<SENT sid="357" pm="."><plain>By convention virus-encoded miRNAs are named in relation to the nearest open reading frame (ORF) transcribed in the same direction as the miRNA; we have followed this convention in naming the OvHV-2-encoded miRNAs. </plain></SENT>
<SENT sid="358" pm="."><plain>Those identified in Levy et al. and discussed in Riaz et al. [22], [27] have been renamed to adhere to this nomenclature (Table 1). </plain></SENT>
<SENT sid="359" pm="."><plain>Two miRNAs are encoded at the left hand end of the genome in the region between the terminal repeat and the 3′ end of ORF Ov2, these have been named ovhv2-miR-Ov2-1 and ovhv2-miR-Ov2-2 (ovhv2-miR-1 in Levy et al. 2012[22]). </plain></SENT>
<SENT sid="360" pm="."><plain>The OvHV-2 genome, like that of AlHV-1 and equine herpesvirus 2 (EHV-2) contains two large regions of the genome with no predicted open reading frames [28]. </plain></SENT>
<SENT sid="361" pm="."><plain>The majority (30) of the identified miRNAs are encoded as two clusters at either end of the larger of these two regions. </plain></SENT>
<SENT sid="362" pm="."><plain>One cluster, spanning 4377 bp at the left end of this region, contains 27 miRNAs; a smaller cluster of three miRNAs is encoded in a 320 bp region at the right hand end of this region (Figure 3). </plain></SENT>
<SENT sid="363" pm="."><plain>These miRNAs have been named ovhv2-miR-17-1 to -30. </plain></SENT>
<SENT sid="364" pm="."><plain>Ovhv2-mir-17- 29, -20, -17, -10, -6, -3 and -1 were previously designated ovhv2-miR-2 to -8. </plain></SENT>
<SENT sid="365" pm="."><plain>One miRNA is encoded in the non-coding region situated toward the right end of the genome and is designated ovhv2-miR-73-1. </plain></SENT>
<SENT sid="366" pm="."><plain>The remaining miRNAs are encoded within ORFs 24 and 61 and are designated ovhv2-miR-24-1 and ovhv2-miR-61-1. </plain></SENT>
</text></p><p><text><SENT sid="367" pm="."><plain>ovhv2-miR-73-1 was the only OvHV-2-encoded miRNA to show seed sequence homology to any other reported miRNA, miR-216a (Figure 1). </plain></SENT>
<SENT sid="368" pm="."><plain>This miRNA is broadly conserved in vertebrates and targets PTEN and YBX1 [29], [30] down regulation of which can lead to increased cell survival, hypertrophy, sclerosis, and a decreased cellular response to stress [31], all symptoms observed in MCF. </plain></SENT>
<SENT sid="369" pm="."><plain>We are currently investigating the cellular genes targeted by ovhv2-miR-73-1. </plain></SENT>
</text></p><p><text><SENT sid="370" pm="."><plain>AlHV-1 is the causative agent of wildebeest-associated MCF and the sequence identity between the individual ORFs of OvHV-2 and AlHV-1 varies from 22–83% ([28]). </plain></SENT>
<SENT sid="371" pm="."><plain>No significant sequence similarity was found between the non-coding regions of the two viruses and Blastn analysis failed to identify miRNAs in the AlHV-1 genome with sequence homology to any OvHV-2 miRNA. </plain></SENT>
<SENT sid="372" pm="."><plain>A lack of conservation of miRNAs between closely-related viruses has also been observed in different Marek's disease virus strains [32]. </plain></SENT>
</text></p><p><text><SENT sid="373" pm="."><plain>Herpesviruses are generally host species specific and are considered to have co-evolved with their natural host [33]. </plain></SENT>
<SENT sid="374" pm="."><plain>Herpesvirus-encoded miRNAs have been shown to regulate both virus and host gene expression [12]–[17] and it is likely that these miRNAs have also co-evolved with their host targets. </plain></SENT>
<SENT sid="375" pm="."><plain>The different disease outcomes seen in sheep (natural, co-evolved host) and cattle (“foreign” host may be the result of different virus:host interactions. </plain></SENT>
<SENT sid="376" pm="."><plain>Our hypothesis is that OvHV-2-miRNAs interact differently with sheep and cattle genes and that these differences play a role in the differing disease outcomes. </plain></SENT>
<SENT sid="377" pm="."><plain>It is likely that AlHV-1 does encode miRNAs, but that they have co-evolved to target wildebeest (natural host) genes in a similar manner to which OvHV-2 miRNAs have evolved to target sheep genes. </plain></SENT>
</text></p><p><text><SENT sid="378" pm="."><plain>The identification of the miRNAs encoded by OvHV-2 allows us to study how these miRNAs affect host and virus gene expression. </plain></SENT>
<SENT sid="379" pm="."><plain>We have recently shown that viral genes ORF20 (cell cycle inhibition), ORF 50 (reactivation) and ORF 73 (latency maintenance) are targeted by ovhv-miR-17-29; ovhv2-miR-17-10 and ovhv2-miR-17-1 respectively[27]. </plain></SENT>
<SENT sid="380" pm="."><plain>The identification of host targets of the 35 OvHV2-miRNAs is not straightforward. </plain></SENT>
<SENT sid="381" pm="."><plain>Bioinformatic analysis of potential targets for the OvHV2-miRNAs in the sheep and cattle genome resulted in the identification of more than 100,000 possible targets in each genome, an unrealistic number to investigate. </plain></SENT>
<SENT sid="382" pm="."><plain>We are current using experimental approaches to investigate cellular targets of the OvHV-2-miRNAs. </plain></SENT>
</text></p></sec></SecTag><SecTag type="SUPPL"><sec sec-type="supplementary-material" id="s5"><title><text><SENT sid="383" pm="."><plain>Supporting Information </plain></SENT>
</text></title><supplementary-material content-type="local-data" id="pone.0097765.s001"><label>Table S1</label><caption><p><text><SENT sid="384" pm="."><plain>Sequences of specific forward PCR primers and related annealing temperatures. The sequence of the forward primers and annealing temperatures used to analyse expression of the predicted ovhv2-miRNAs are shown. </plain></SENT>
<SENT sid="385" pm="."><plain>Those miRNAs which were successfully validated using approach are shown in bold. “Group 1” etc. represent predicted miRNAs which were not shown to be expressed. </plain></SENT>
</text></p><p><text><SENT sid="386" pm="."><plain>(DOCX) </plain></SENT>
</text></p></caption><media xlink:href="pone.0097765.s001.docx"><caption><p><text><SENT sid="387" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0097765.s002"><label>Table S2</label><caption><p><text><SENT sid="388" pm="."><plain>Sequence of miRNA specific Reverse transcription primers and specific 5′ forward primers. For each of the miRNAs which were not validated using the miScript assay, the sequence of the primers used to prime cDNA synthesis, the specific 5′ forward primers and the sequence of the universal reverse PCR primer are shown. “Group 1” etc. represent predicted miRNAs which were not shown to be expressed. </plain></SENT>
</text></p><p><text><SENT sid="389" pm="."><plain>(DOCX) </plain></SENT>
</text></p></caption><media xlink:href="pone.0097765.s002.docx"><caption><p><text><SENT sid="390" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><p><text4fund><text><SENT sid="391" pm="."><plain>We thank Dr G Russell, Moredun Research Institute, for the kind gift of BJ1035 cells. </plain></SENT>
</text></text4fund></p></ack></SecTag><SecTag type="REF"><ref-list><title>References</title><ref id="pone.0097765-Russell1"><text><SENT sid="392" pm="."><plain>1 RussellGC, StewartJP, HaigDM (2009) Malignant catarrhal fever: A review. Veterinary Journal 179: 324–335. </plain></SENT>
</text></ref><ref id="pone.0097765-MeierTrummer1"><text><SENT sid="393" pm="."><plain>2 Meier-TrummerCS, RyfB, AckermannM (2010) Identification of peripheral blood mononuclear cells targeted by Ovine herpesvirus-2 in sheep. Veterinary Microbiology 141: 199–207.19783107 </plain></SENT>
</text></ref><ref id="pone.0097765-Schock1"><text><SENT sid="394" pm="."><plain>3 SchockA, CollinsRA, ReidHW (1998) Phenotype, growth regulation and cytokine transcription in Ovine Herpesvirus-2 (OHV-2)-infected bovine T-cell lines. Veterinary Immunology and Immunopathology 66: 67–68.9847021 </plain></SENT>
</text></ref><ref id="pone.0097765-Sun1"><text><SENT sid="395" pm="."><plain>4 SunJC, LanierLL (2011) NK cell development, homeostasis and function: parallels with CD8(+) T cells. Nature Reviews Immunology 11: 645–657. </plain></SENT>
</text></ref><ref id="pone.0097765-Reid1"><text><SENT sid="396" pm="."><plain>5 ReidHW, BuxtonD, PowI, FinlaysonJ (1989) Isolation and characterisation of lymphoblastoid cells from cattle and deer affected with ‘sheep-associated’ malignant catarrhal fever. Res Vet Sci 47: 90–96.2772411 </plain></SENT>
</text></ref><ref id="pone.0097765-Bartel1"><text><SENT sid="397" pm="."><plain>6 BartelDP (2009) MicroRNAs: Target Recognition and Regulatory Functions. Cell 136: 215–233.19167326 </plain></SENT>
</text></ref><ref id="pone.0097765-Carthew1"><text><SENT sid="398" pm="."><plain>7 CarthewRW, SontheimerEJ (2009) Origins and Mechanisms of miRNAs and siRNAs. Cell 136: 642–655.19239886 </plain></SENT>
</text></ref><ref id="pone.0097765-Kim1"><text><SENT sid="399" pm="."><plain>8 KimVN, HanJ, SiomiMC (2009) Biogenesis of small RNAs in animals. Nature Reviews Molecular Cell Biology 10: 126–139.19165215 </plain></SENT>
</text></ref><ref id="pone.0097765-Cullen1"><text><SENT sid="400" pm="."><plain>9 CullenBR (2009) Viral and cellular messenger RNA targets of viral microRNAs. Nature 457: 421–425.19158788 </plain></SENT>
</text></ref><ref id="pone.0097765-Glazov1"><text><SENT sid="401" pm="."><plain>10 GlazovEA, HorwoodPF, AssavalapsakulW, KongsuwanK, MitchellRW, et al (2010) Characterization of microRNAs encoded by the bovine herpesvirus 1 genome. Journal of General Virology 91: 32–41.19793906 </plain></SENT>
</text></ref><ref id="pone.0097765-Grey1"><text><SENT sid="402" pm="."><plain>11 GreyF, HookL, NelsonJ (2008) The functions of herpesvirus-encoded microRNAs. Medical Microbiology and Immunology 197: 261–267.18087721 </plain></SENT>
</text></ref><ref id="pone.0097765-Dolken1"><text><SENT sid="403" pm="."><plain>12 DolkenL, KrmpoticA, KotheS, TuddenhamL, TanguyM, et al (2010) Cytomegalovirus microRNAs facilitate persistent virus infection in salivary glands. PLoS Pathog 6: e1001150.20976200 </plain></SENT>
</text></ref><ref id="pone.0097765-Gottwein1"><text><SENT sid="404" pm="."><plain>13 GottweinE, CullenBR (2010) A Human Herpesvirus MicroRNA Inhibits p21 Expression and Attenuates p21-Mediated Cell Cycle Arrest. Journal of Virology 84: 5229–5237.20219912 </plain></SENT>
</text></ref><ref id="pone.0097765-Lu1"><text><SENT sid="405" pm="."><plain>14 LuF, StedmanW, YousefM, RenneR, LiebermanPM (2010) Epigenetic Regulation of Kaposi's Sarcoma-Associated Herpesvirus Latency by Virus-Encoded MicroRNAs That Target Rta and the Cellular Rbl2-DNMT Pathway. Journal of Virology 84: 2697–2706.20071580 </plain></SENT>
</text></ref><ref id="pone.0097765-Qin1"><text><SENT sid="406" pm="."><plain>15 QinZ, KearneyP, PlaisanceK, ParsonsCH (2010) Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes. Journal of Leukocyte Biology 87: 25–34.20052801 </plain></SENT>
</text></ref><ref id="pone.0097765-Seto1"><text><SENT sid="407" pm="."><plain>16Seto E, Moosmann A, Groemminger S, Walz N, Grundhoff A, et al.. </plain></SENT>
<SENT sid="408" pm="."><plain>(2010) Micro RNAs of Epstein-Barr Virus Promote Cell Cycle Progression and Prevent Apoptosis of Primary Human B Cells. </plain></SENT>
<SENT sid="409" pm="."><plain>PLoS Pathogens 6. </plain></SENT>
</text></ref><ref id="pone.0097765-Zhao1"><text><SENT sid="410" pm="."><plain>17 ZhaoYG, YaoYX, XuHT, LambethL, SmithLP, et al (2009) A Functional MicroRNA-155 Ortholog Encoded by the Oncogenic Marek's Disease Virus. Journal of Virology 83: 489–492.18945769 </plain></SENT>
</text></ref><ref id="pone.0097765-Feederle1"><text><SENT sid="411" pm="."><plain>18 FeederleR, HaarJ, BernhardtK, LinnstaedtSD, BannertH, et al (2011) The Members of an Epstein-Barr Virus MicroRNA Cluster Cooperate To Transform B Lymphocytes. Journal of Virology 85: 9801–9810.21752900 </plain></SENT>
</text></ref><ref id="pone.0097765-Feederle2"><text><SENT sid="412" pm="."><plain>19Feederle R, Linnstaedt SD, Bannert H, Lips H, Bencun M, et al.. </plain></SENT>
<SENT sid="413" pm="."><plain>(2011) A Viral microRNA Cluster Strongly Potentiates the Transforming Properties of a Human Herpesvirus. </plain></SENT>
<SENT sid="414" pm="."><plain>Plos Pathogens 7. </plain></SENT>
</text></ref><ref id="pone.0097765-Zhao2"><text><SENT sid="415" pm="."><plain>20Zhao Y, Xu H, Yao Y, Smith LP, Kgosana L, et al.. </plain></SENT>
<SENT sid="416" pm="."><plain>(2011) Critical Role of the Virus-Encoded MicroRNA-155 Ortholog in the Induction of Marek's Disease Lymphomas. </plain></SENT>
<SENT sid="417" pm="."><plain>Plos Pathogens 7. </plain></SENT>
</text></ref><ref id="pone.0097765-Levy1"><text><SENT sid="418" pm="."><plain>21Levy CS (2011) Identification and Characterisation of Ovine Herpesvirus 2 microRNAs. </plain></SENT>
<SENT sid="419" pm="."><plain>PhD Thesis University of Edinburgh. </plain></SENT>
</text></ref><ref id="pone.0097765-Levy2"><text><SENT sid="420" pm="."><plain>22 LevyCS, HopkinsJ, RussellG, DalzielRG (2012) Novel virus-encoded microRNA molecules expressed by ovine herpesvirus 2 immortalized bovine T cells. Journal of General Virology 93: 150–154.21957125 </plain></SENT>
</text></ref><ref id="pone.0097765-Bujdoso1"><text><SENT sid="421" pm="."><plain>23 BujdosoR, YoungP, HopkinsJ, McConnellI (1990) IL-2 like activity in lymph fluid following in vivo antigen challenge. Immunology 69: 45–51.2312156 </plain></SENT>
</text></ref><ref id="pone.0097765-VarkonyiGasic1"><text><SENT sid="422" pm="."><plain>24Varkonyi-Gasic E, Wu R, Wood M, Walton EF, Hellens RP (2007) Protocol: a highly sensitive RT-PCR method for detection and quantification of microRNAs. </plain></SENT>
<SENT sid="423" pm="."><plain>Plant Methods 3. </plain></SENT>
</text></ref><ref id="pone.0097765-Grundhoff1"><text><SENT sid="424" pm="."><plain>25 GrundhoffA, SullivanCS (2011) Virus-encoded microRNAs. Virology 411: 325–343.21277611 </plain></SENT>
</text></ref><ref id="pone.0097765-Walz1"><text><SENT sid="425" pm="."><plain>26 WalzN, ChristallaT, TessmerU, GrundhoffA (2010) A Global Analysis of Evolutionary Conservation among Known and Predicted Gammaherpesvirus MicroRNAs. Journal of Virology 84: 716–728.19889779 </plain></SENT>
</text></ref><ref id="pone.0097765-Riaz1"><text><SENT sid="426" pm="."><plain>27 RiazA, DryI, LevyCS, HopkinsJ, GreyF, et al (2014) Ovine herpesvirus-2-encoded microRNAs target virus genes involved in virus latency. Journal of General Virology 95: 472–480.24172907 </plain></SENT>
</text></ref><ref id="pone.0097765-Hart1"><text><SENT sid="427" pm="."><plain>28 HartJ, AckermannM, JayawardaneG, RusseG, HaigDM, et al (2007) Complete sequence and analysis of the ovine herpesvirus 2 genome. Journal of General Virology 88: 28–39.17170433 </plain></SENT>
</text></ref><ref id="pone.0097765-Kato1"><text><SENT sid="428" pm="."><plain>29 KatoM, PuttaS, WangM, YuanH, LantingL, et al (2009) TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nature Cell Biology 11: 881–U263.19543271 </plain></SENT>
</text></ref><ref id="pone.0097765-Kato2"><text><SENT sid="429" pm="."><plain>30 KatoM, WangL, PuttaS, WangM, YuanH, et al (2010) Post-transcriptional Up-regulation of Tsc-22 by Ybx1, a Target of miR-216a, Mediates TGF-beta-induced Collagen Expression in Kidney Cells. Journal of Biological Chemistry 285: 34004–34015.20713358 </plain></SENT>
</text></ref><ref id="pone.0097765-Evdokimova1"><text><SENT sid="430" pm="."><plain>31 EvdokimovaV, RuzanovP, AnglesioMS, SorokinAV, OvchinnikovLP, et al (2006) Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species. Molecular and Cellular Biology 26: 277–292.16354698 </plain></SENT>
</text></ref><ref id="pone.0097765-Yao1"><text><SENT sid="431" pm="."><plain>32 YaoY, ZhaoY, XuH, SmithLP, LawriesCH, et al (2007) Marek's disease virus type 2 (MDV-2)-encoded microRNAs show no sequence conservation with those encoded by MDV-1. Journal of Virology 81: 7164–7170.17459919 </plain></SENT>
</text></ref><ref id="pone.0097765-McGeoch1"><text><SENT sid="432" pm="."><plain>33 McGeochDJ, RixonFJ, DavisonAJ (2006) Topics in herpesvirus genomics and evolution. Virus Research 117: 90–104.16490275 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
